CONTINUING EDUCATION:
RN, NP: 1.0 CE Credit (0.3 Pharmacology)
Recorded Date: April 10, 2015 (as part of the 2015 PCNA annual symposium in Anaheim)
Original Posting Date: January 27, 2016
Content Review Date: January 2017
COURSE OVERVIEW:
A review of important secondary prevention strategies embedded in a case-based approach.
EDUCATIONAL OBJECTIVES:
- Review optimal guideline directed optimal management of patients with ACS
- Discuss adherence to medication and lifestyle therapies in patients with ACS
AUDIENCE:
Nurses, advanced practice nurses, and other healthcare providers interested in the prevention and management of cardiovascular disease.
FACULTY DISCLOSURES:
- ARAGON – Speaker’s bureau: The Medicines Company, AstraZeneca, Boston Scientific and Abbott Vascular; Research grant: The Medicines Company
- BROZ – Speaker’s bureau: Gilead Sciences
The faculty members have declared no commercial relationships related to the content of this presentation.
COST:
This online educational activity is offered free of charge.
PARTICIPATION IN THE ACTIVITY AND RECEIPT OF CERTIFICATE OF CREDIT:
View the course materials; complete the post-test (you can take the post-test more than once if needed to achieve a passing score of 75%) and online evaluation form at the end of the activity, and print your CE certificate.
ACCREDITOR:
This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is accredited by the American Association of Nurse Practitioners (AANP) as an approved provider of Nurse Practitioner continuing education, provider number 030602.
Please note that if you received credit for attending the 2015 PCNA Annual Symposium in Anaheim, you will be unable to claim credit for the on-demand sessions that were recorded there.
GRANTOR:
This activity is being presented by The Preventive Cardiovascular Nurses Association (PCNA) through an educational grant from AstraZeneca Pharmaceuticals and Merck & Co, Inc.
Seminar Date:
April 10, 2015
- Review optimal guideline directed optimal management of patients with ACS
- Discuss adherence to medication and lifestyle therapies in patients with ACS
PARTICIPATION IN THE ACTIVITY AND RECEIPT OF CERTIFICATE OF CREDIT:
View the course materials; complete the post-test (you can take the post-test more than once if needed to achieve a passing score of 75%) and online evaluation form at the end of the activity, and print your CE certificate.
ACCREDITOR:
This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602.
General Hour: 0.70
Pharmacology Hours: 0.30
